Showing results (81-90 of 610) with videos related to

Sort By:
Pageof 61
Thrombosis and Haemostasis|August 31, 1984
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technologyC Zamarron, H R Lijnen, B Van Hoef, et al.
The Journal of Biological Chemistry|August 5, 1987
Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activatorL Nelles, H R Lijnen, D Collen, et al.
Biochimica Et Biophysica Acta|July 10, 2007
Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesityH R Lijnen, B Van Hoef, D Kemp, et al.
Thrombosis and Haemostasis|October 1, 1995
Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in miceH R Lijnen, L Moons, V Beelen, et al.
Thrombosis and Haemostasis|August 2, 1993
Functional properties of p-anisoylated plasmin-staphylokinase complexH R Lijnen, B Van Hoef, R A Smith, et al.
Thrombosis and Haemostasis|December 27, 1982
Kinetics of the inhibition of plasmin in acidified human plasmaH R Lijnen, M Maes, M Castel, et al.
Blood|May 15, 1989
The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitroH R Lijnen, B Van Hoef, F De Cock, et al.
Thrombosis and Haemostasis|August 13, 1990
Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PAH R Lijnen, B Van Hoef, F De Cock, et al.
Blood|July 1, 1991
Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism modelH R Lu, H R Lijnen, J M Stassen, et al.
Drugs|September 1, 1989
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agentD Collen, H R Lijnen, P A Todd, et al.
Pageof 61